4 TECH OUTLOOKDecember - 2019Impact of New Technologies in Early Clinical DevelopmentIN MY OPINION12J. Fred Pritchard, Ph.D. Vice-President, Strategic Development, Celerion Inc.08LAST WORDRichard Hu, Associate Director CMC, Curis [NASDAQ:CRIS]Recent Trend and Development in Pharmaceutical Industry34COVER STORYBioelectronicaElectrofluidics: New Tools for Drug Discovery and DiagnosticsRoger Chen, Founder and PresidentDr. Jonathan Hull, Co-Founder and Vice President
< Page 3 | Page 5 >